BAUSCH & LOMB PHARMA

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent du commissaire",
      "person": {
        "rrn": null,
        "name": "Loris Guidi",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Eberhard Kuehne",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Pausch \u0026 Lomb Pharma"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": true
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Loris Guid\u00EC",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Pierre Guibourg",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": "2019-06-17",
    "act_kind_objet": "OPERATION ASSIMILEE A UNE FUSION PAR ABSORPTION DE \u0022BAUSCH \u0026"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-07-31",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "acquiring",
        "address": "1030 Schaerbeek, Boulevard Lambermont 430",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb",
        "role": "absorbed",
        "address": "1030 Schaerbeek, Boulevard Lambermont 430",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "719"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2019-01-01",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le patrimoine entier de la soci\u00E9t\u00E9 absorb\u00E9e, sans exception ni r\u00E9serve, est transf\u00E9r\u00E9 \u00E0 titre universel \u00E0 la soci\u00E9t\u00E9 absorbante.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0439.621.618",
    "org_name": "NautaDutilh SPRL",
    "person_name": null,
    "org_rep_person_name": "Louise-Anne Bertin"
  },
  "summary_narrative": "Le 31 juillet 2019, l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme Bausch \u0026 Lomb Pharma, si\u00E9geant \u00E0 Schaerbeek, a approuv\u00E9 une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption, par laquelle Bausch \u0026 Lomb Pharma absorbe la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e Bausch \u0026 Lomb, \u00E9galement situ\u00E9e \u00E0 Schaerbeek. Le transfert porte sur l\u0027ensemble du patrimoine de la soci\u00E9t\u00E9 absorb\u00E9e \u00E0 titre universel, avec effet comptable \u00E0 partir du 1er janvier 2019.",
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "deux procurations"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SCRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SCRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  }
}

{
  "stage": "proposal",
  "notary": {
    "name": "Julie Salteur, Louise-Anne Bertin",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2019-06-27",
    "filing_date": "2019-06-18",
    "act_kind_objet": "D\u00E9p\u00F4t d\u0027un projet commun de fusion par absorption simplifi\u00E9e"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-06-17",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma SA",
        "role": "acquiring",
        "address": "Boulevard Lambermont 430, 1030 Schaerbeek",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0461.095.240",
        "name": "Bausch \u0026 Lomb SPRL",
        "role": "absorbed",
        "address": "Boulevard Lambermont 430, 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "676, 1\u00B0",
      "719",
      "720 \u00A72"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2018-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027ensemble du patrimoine, tant actif que passif, de Bausch \u0026 Lomb SPRL est transf\u00E9r\u00E9 \u00E0 Bausch \u0026 Lomb Pharma SA par dissolution sans liquidation.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0461.095.240",
    "org_name": "NautaDutilh",
    "person_name": null,
    "org_rep_person_name": "Louise-Anne Bertin"
  },
  "summary_narrative": "Les soci\u00E9t\u00E9s Bausch \u0026 Lomb Pharma SA et Bausch \u0026 Lomb SPRL, toutes deux \u00E9tablies \u00E0 Bruxelles, ont conjointement r\u00E9dig\u00E9 un projet commun de fusion par absorption simplifi\u00E9e, conform\u00E9ment aux articles 676, 1\u00B0 et 719 du Code des soci\u00E9t\u00E9s. L\u0027op\u00E9ration pr\u00E9voit la transmission int\u00E9grale du patrimoine de Bausch \u0026 Lomb SPRL \u00E0 Bausch \u0026 Lomb Pharma SA, sans liquidation de la soci\u00E9t\u00E9 absorb\u00E9e, avec effet r\u00E9troactif au 1er janvier 2019. Le projet a \u00E9t\u00E9 d\u00E9pos\u00E9 au greffe du tribunal de commerce de Bruxelles le 18 juin 2019 et publi\u00E9 aux Annexes du Moniteur belge le 27 juin 2019.",
  "co_filed_documents": [
    "le-projet-commun-de-fusion-par-absorption-simplifi\u00E9e-sign\u00E9-le-17-juin-2019"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Nathalie Van Landuyt",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2018-06-21",
    "filing_date": "2018-06-12",
    "act_kind_objet": "Publication conform\u00E9ment \u00E0 l\u0027article 556 C. Soc."
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2018-05-15",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "other",
        "address": "boulevard Lambermont 430 - 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Thibaut Willems",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Nathalie Van Landuyt",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "NautaDutilh",
        "role": "other",
        "address": "1000 Bruxelles, Chauss\u00E9e de La Hulpe 120",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556 C. Soc."
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le mandat concerne les formalit\u00E9s de d\u00E9p\u00F4t et de publication du proc\u00E8s-verbal, sans transfert de patrimoine.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nathalie Van Landuyt",
    "org_rep_person_name": null
  },
  "summary_narrative": "Les actionnaires de Bausch \u0026 Lomb Pharma ont d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9, par \u00E9crit, le 15 mai 2018, de nommer Thibaut Willems, Nathalie Van Landuyt et/ou tout avocat du cabinet NautaDutilh, si\u00E9geant \u00E0 Bruxelles, en tant que mandataires sp\u00E9ciaux de la soci\u00E9t\u00E9. Ces mandataires ont pour mission d\u0027accomplir toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent proc\u00E8s-verbal au greffe du tribunal de commerce de Bruxelles et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Linda Ann LaGorga",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "William Norman Woodfield",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Nathalie Van Landuyt",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": null,
    "act_kind_objet": "Publication conform\u00E9ment \u00E0 l\u0027article 556 C. Soc."
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "act_date": "2018-03-01",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma SA",
        "role": "other",
        "address": "boulevard Lambermont, 430 - 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Fr\u00E9d\u00E9ric Heremans",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Pierre De Pauw",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Silke Volckaert",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Nathalie Van Landuyt",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "NautaDutilh",
        "role": "other",
        "address": "1000 Bruxelles, Chauss\u00E9e de La Hulpe 120",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le mandat concerne l\u0027accomplissement de toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent proc\u00E8s-verbal au greffe du Tribunal de Commerce et \u00E0 sa publication au Moniteur belge, ainsi que l\u0027approbation et la signature de tout acte ou document relatif \u00E0 ces formalit\u00E9s.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nathalie Van Landuyt",
    "org_rep_person_name": null
  },
  "summary_narrative": "Les actionnaires de Bausch \u0026 Lomb Pharma SA ont d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9, par \u00E9crit, le 1er mars 2018, de d\u00E9signer comme mandataires sp\u00E9ciaux Fr\u00E9d\u00E9ric Heremans, Pierre De Pauw, Silke Volckaert, Nathalie Van Landuyt et/ou tout avocat du cabinet NautaDutilh, pour agir au nom et pour le compte de la soci\u00E9t\u00E9 aux fins de remplir toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent acte au greffe du Tribunal de Commerce et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Marcin Jedrzejuk",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Eberhard Kuehne",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Ling Zeng",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SC SCRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Pierre Guibourg",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  }
}

{
  "stage": null,
  "notary": {
    "name": "Pierre De Pauw",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2016-02-24",
    "filing_date": "2016-01-26",
    "act_kind_objet": ""
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2016-01-26",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "other",
        "address": "Boulevard Lambermont 430, 1030 Schaerbeek",
        "is_foreign": false,
        "legal_form": "soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Fr\u00E9d\u00E9ric Heremans",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Pierre De Pauw",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "NautaDutilh",
        "role": "other",
        "address": "1000 Bruxelles, Chauss\u00E9e de La Hulpe 120",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Aucun transfert de patrimoine n\u0027est effectu\u00E9. L\u0027acte concerne uniquement la d\u00E9signation de mandataires sp\u00E9ciaux pour le d\u00E9p\u00F4t et la publication du proc\u00E8s-verbal.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Pierre De Pauw",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de Bausch \u0026 Lomb Pharma s\u0027est r\u00E9unie le 26 janvier 2016 et a d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9 de d\u00E9signer Fr\u00E9d\u00E9ric Heremans, Pierre De Pauw et/ou tout avocat du cabinet NautaDutilh comme mandataires sp\u00E9ciaux de la soci\u00E9t\u00E9. Leur mission est d\u0027accomplir toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent acte au greffe du tribunal de commerce et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "director_changes"
}

{
  "stage": null,
  "notary": {
    "name": "Pierre De Pauw",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2016-02-12",
    "filing_date": "2016-01-26",
    "act_kind_objet": ""
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2016-01-26",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "other",
        "address": "Boulevard Lambermont 430, 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Le transfert concerne les pouvoirs de repr\u00E9sentation et de gestion n\u00E9cessaires au d\u00E9p\u00F4t du proc\u00E8s-verbal au greffe du tribunal de commerce et \u00E0 sa publication au Moniteur belge.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Pierre De Pauw",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de Bausch \u0026 Lomb Pharma, r\u00E9unie le 26 janvier 2016, a d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9 de d\u00E9signer Pierre De Pauw, Fr\u00E9d\u00E9ric Heremans et tout avocat du cabinet NautaDutilh \u00E0 Bruxelles comme mandataires sp\u00E9ciaux de la soci\u00E9t\u00E9. Leur mandat, irr\u00E9vocable et valable trois mois, couvre toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du proc\u00E8s-verbal au greffe du tribunal de commerce et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}